Facebook
Twitter
LinkedIn
ForwardInaugural Miami Cancer Institute Precision Oncology Symposium
Live Symposium | 8.25 Cat. 1
February 3-4, 2023 | Friday-Saturday
The Biltmore Hotel, Coral Gables, Florida
Given the increasing discovery of oncogenic-driven tumors, targeted treatments with novel agents have transformed the outcomes in these patients. Clinical decision making and management therefore have become more complex. There is a need to provide an opportunity for medical oncologists, radiation oncologists, pathologists, allied health professionals, oncology nurses and pharmacists to engage in thoughtful discussions with experts in these fields. In addition, there is emerging data about the biology of these malignancies impacting optimal management of patients with these disorders.
This one-and-a-half-day symposium has been designed to provide an overview and opportunity to learn about the most recent advances in the treatment of solid tumors, including lung cancer, breast cancer, gastrointestinal tumors, genitourinary tumors, head and neck tumors, melanoma, sarcoma, brain tumors by novel targeted agents and treatment combinations. Updates on evolving molecular-based system therapies will be profiled and discussed.
Agenda
Friday, February 3
| 8:00 a.m. | Welcome and Product Theater |
| 8:30 a.m. | Registration and Breakfast |
| 8:50 a.m. | Welcome and Keynote Introductions Manmeet Ahluwalia, M.D. |
| 8:55 a.m. | CEO Remarks Michael Zinner, M.D. |
| Precision Oncology Keynotes | |
| 9:00 a.m. | Immunoablative Therapy Luis Diaz, M.D. |
| 9:30 a.m. | Re-imagining the (R)evolution in the Precision Oncology Paradigm Vivek Subbiah, M.D. |
| GI & Sarcoma | |
| 10:00 a.m. | Precision Oncology in Advanced Colorectal Cancer (aCRC) Tanios Bekaii-Saab, M.D. |
| 10:20 a.m. | HER2 Targeted Treatments: How Low Can You Go? Jenny Chang, M.D. |
| 10:40 a.m. | Targeted Therapy for the Management of Cervical Cancer Thomas Herzog, M.D. |
| 11:00 a.m. | Break |
| Lung | |
| 11:15 a.m. | Precision Oncology Approaches in Uncommon Mutations in Lung Cancer Luis Raez, M.D. |
| 11:35 a.m. | Precision Oncology Approaches in Common Mutations in Lung Cancer Charu Aggarwal, M.D. |
| 11:55 a.m. | Precision Oncology Approaches in Phase 1 Trials Nagla Karim, M.D. |
| 12:15 p.m. | Lunch Break |
| 12:45 p.m. | Product Theater |
| 1:15 p.m. | Break and Visit Exhibits |
| Gyn-Onc | |
| 1:45 p.m. | Endometrial Cancer Therapy During the Era of Precision Medicine Roisin O'Cearbhaill, M.D. |
| 2:05 p.m. | Gastrointestinal Stromal Tumors: The GIST of Precision Medicine Jonathan Trent, M.D. |
| 2:25 p.m. | Role of Precision Medicine in the Management of Ovarian Cancer John Diaz, M.D. |
| 2:45 p.m. | Break and Visit Exhibits |
| Breast | |
| 3:00 p.m. | Targeted Therapy for ER+/HER2-MBC: CDK4/6 Inhibition and Beyond Reshma Mahtani, D.O. |
| 3:20 p.m. | Dividing and Conquering Sarcomas Through Precision Oncology Neeta Somaiah, M.D. |
| 3:40 p.m. | Precision Oncology in Brain Metastases: Past, Present and Future Manmeet Ahluwalia, M.D. |
| 4:00 p.m. | Closing Remarks Manmeet Ahluwalia, M.D. |
| 4:30 p.m. | Product Theater |
| 5:00 p.m. | Visit Exhibits |
| 5:30 p.m. | Networking Event |
Saturday, February 4
| 8:00 a.m. | Welcome and Product Theater |
| 8:30 a.m. | Registration and Breakfast |
| 8:55 a.m. | Welcome and Introductions Manmeet Ahluwalia, M.D. |
| GU | |
| 9:00 a.m. | Precision Oncology Opportunities in Head and Neck Cancer Everett Vokes, M.D. |
| 9:20 a.m. | Precision Oncology in Metastatic Prostate Cancer: Current and Emerging Paradigms Neeraj Agarwal, M.D. |
| 9:40 a.m. | Applying Precision Medicine to Rare Subtypes of Renal Cell Carcinoma Pal Sumanta, M.D. |
| Symposium Keynote Address | |
| Keynote Speaker Introduction Manmeet Ahluwalia, M.D. | |
| 10:00 a.m. | ASCO’s Journey of Precision Medicine: The TAPUR Experience Julie R. Gralow, M.D. |
| 10:30 a.m. | Break and Visit Exhibits |
| CNS | |
| 10:50 a.m. | Precision Oncology Approaches in Gliomas Patrick Wen, M.D. |
| 11:10 a.m. | Updates and Future Directions in the Management of Metastatic TNBC Tiffany Traina, M.D. |
| Head, Neck, and Skin | |
| 11:30 a.m. | Precision Oncology Approaches in Melanoma Pauline Funchain, M.D. |
| 11:50 a.m. | Updates in the Management of Advanced/Metastatic Urothelial Carcinoma Petros Grivas, M.D. |
| 12:10 p.m. | TBD |
| 12:30 p.m. | Closing Remarks Manmeet Ahluwalia, M.D. |
| 1:00 p.m. | Product Theater |
| 1:30 p.m. | Networking Event |
NOTE: Schedule subject to change.
Meeting is in the Conference Center, Merrick Ballroom, next to the pool and the free parking lot.
With a timeless appeal and style, The Biltmore Hotel is Miami’s most elegant National Historic Landmark. Spanning over 150 acres of tropical landscape, this resort includes 174 suites and features spectacular Mediterranean architecture with Italian, Moorish and Spanish influences. Explore downtown Coral Gables renowned restaurants, boutiques, businesses, and the illustrious Miracle Mile, all within minutes—or venture to Miami Beach and other major Miami attractions.
A favorite of world leaders and celebrities since its opening in 1926, the hotel offers a restored Donald Ross 18-hole, 71-par championship golf course, tennis courts, a European Spa, modern Fitness Center, and the largest Hotel Pool on the East Coast of the United States.
The hotel’s dining destinations include Fontana, a traditional Italian restaurant surrounding The Biltmore courtyard and fountain; the poolside Cascade, and the golf-themed 19th Hole restaurant.
Travel
The drive time between The Biltmore Hotel and Miami International Airport (MIA) is around 18 minutes and covers a distance of around 3.7 miles.
Symposium Director
Fernandez Family Foundation Endowed Chair in Cancer Research
Chief of Medical Oncology
Chief Scientific Officer & Deputy Director
Miami Cancer Institute
Baptist Health South Florida
Miami, Florida
Faculty
Urologic Oncologist
Senior Director of Clinical Research Innovation
Huntsman Cancer Institute
University of Utah
Salt Lake City, Utah
Medical Oncologist
Associate Director
Penn Center for Precision Oncology
Associate Professor
Lung Cancer Excellence
Philadelphia, PA
Medical Oncologist
Medical Director
Cancer Clinical Research Office
Chief Medical Oncologist
Mayo Clinic
Phoenix, Arizona
Emily Herrmann Presidential Distinguished Chair in Cancer Research
Dr. Mary and Ron Neal Cancer Center
Professor of Medicine in Oncology
Academic Institute
Full Member, Research Institute
Houston Methodist
Weill Cornell Medical College
Houston, Texas
Chief of Gynecologic Oncology
Medical Director of Robotic Surgery, Baptist Health South Florida
Medical Director of Baptist Health Surgical Center, Plantation
Lead Physician Clinical Research, Gynecologic Oncology Clinical Trials
Miami Cancer Institute Miami, Florida
Medical Oncologist
Head of the Division of Solid Tumor Oncology
Grayer Family Chair
Memorial Sloan Kettering
New York, New York
Director of Melanoma and Genomics
Cleveland Clinic
Cleveland, Ohio
Chief of Genitourinary Oncology
Miami Cancer Institute
Miami, Florida
Professor of Medical Oncology
Director of Breast Medical Oncology
University of Washington
Fred Hutchinson Cancer Research Center
Chief Medical Officer – ASCO
Seattle, Washington
Medical Oncologist
Professor, Division of Medical Oncology
Clinical Director, Genitourinary Cancers Program
University of Washington Medicine
Seattle, Washington
Paul & Carolyn Flory Professor
University of Cincinnati
Deputy Director
University of Cincinnati Cancer Center (UCCC)
Assoc Director GOG Partners
Cincinnati, Ohio
Director of Early Therapeutics Program
Inova Schar Cancer Institute
Professor of Medicine
University of Virginia
Fairfax, Virginia
Chief of Breast Medical Oncology
Miami Cancer Institute
Miami, Florida
Medical Oncologist
Associate Attending Physician
Memorial Sloan Kettering Cancer Center
New York, New York
Medical Oncologist
City of Hope Comprehensive Cancer Center
Duarte, California
Chief Scientific Officer & Medical Director
Memorial Cancer Institute/Memorial Health Care System
Co-Director MCI/FAU Florida Cancer Center of Excellence
Research Professor Florida Atlantic University (FAU)
Past-President Florida Society of Clinical Oncology (FLASCO)
Hollywood, Florida
Sarcoma Medical Oncologist
Associate Professor
Department of Sarcoma Medical Oncology
Division of Cancer Medicine
The University of Texas
MD Anderson Cancer Center
Houston, Texas
Associate Professor
Department of Investigational Cancer Therapeutics
Division of Cancer Medicine
The University of Texas
MD Anderson Cancer Center
Houston, Texas
Medical Oncologist
Vice Chair of Outpatient Operations
Department of Medicine Section Head
Triple Negative Breast Cancer Clinical Research Program
Memorial Sloan Kettering
New York, New York
Professor of Medicine
Associate Director for Clinical Research
Director, Sarcoma Medical Research Program
Sylvester Comprehensive Cancer Center
University of Miami, Miller School of Medicine
Miami, Florida
John E. Ultmann Professor
Chairman, Department of Medicine
Physician-in-Chief, University of Chicago Medicine and Biological Sciences
Chicago, Illinois
Neuro-oncology
Dana-Farber Cancer Institute
Boston, Massachusetts
Accreditation
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this live activity for a maximum of 8.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been approved for a total of 8.25 credit hours, CE Broker Course # 20-972440 and 20-972444, by the Florida Boards of Medicine, Osteopathic Medicine and by the Florida Council of Physician Assistants.
This activity has been approved for 8.0 credits for Nurse Practitioners and Nurses. Baptist Health South Florida CE Broker Provider #50-182.
This activity has been approved for 8.25 credits for Pharmacists and Pharmacy Technicians. Baptist Health South Florida CE Broker Provider #50-182.
This activity has been approved for 8.20 credits for Laboratory Personnel in Molecular Pathology. Baptist Health South Florida CE Broker Provider #50-182.
The American Academy of Nurse Practitioners Certification Board (AANPCB) accepts CEs accredited by the ACCME. Individuals are responsible for checking with the AANPCB for further guidelines.
AMA PRA Category 1 Credits™ claimed by physicians attending live events certified and organized in the United States for AMA PRA Category 1 Credits™ can be claimed through the agreement on mutual recognition of credits between UEMS and AMA, considered as being equal to the European Continuous Medical Education Credits (ECMEC©) granted by the UEMS. One AMA PRA Category 1 Credit™ is equivalent to one (1) hour of European EACCME Credit (ECMEC©). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Disclaimer
Baptist Health South Florida presents this CME activity for use by healthcare professionals for educational purposes only. Opinions, perspectives and information presented by the faculty represent their ideas and views, and participants should carefully consider all available scientific data before acting on knowledge gained through this activity. Additionally, participants should consult the US Food and Drug Administration (FDA) for approved uses prior to prescribing medications or utilizing medical devices discussed in this activity.
While Baptist Health makes reasonable efforts to ensure that accurate information is presented, no warranty, expressed or implied, is offered. Participants should rely on their own clinical judgment, knowledge and experience before applying information acquired to their professional use.
Available Credit
- 8.25 AMA PRA Category 1 Credit™
- 8.25 General certificate of attendance
- 8.20 Florida Board of Laboratory Personnel
- 8.00 Nurse Practitioners
- 8.00 Florida Board of Nursing
- 8.25 Florida Board of Pharmacy
We gratefully acknowledge the following exhibitors:
AstraZeneca Oncology-Lung
Bayer
Bristol Myers Squibb
Caris Life Sciences
Daiichi Sankyo
Eisai
GlaxoSmithKline
Guardant Health
Janssen Oncology
Kiyatec
Lilly Oncology
Merck Oncology
Novartis Pharmaceuticals
Pfizer Oncology
Pharmacosmos Therapeutics
Regeneron
Seagen
Tempus
We gratefully acknowledge the following first-time exhibitors:
Aveo Oncology
Cellworks
Deciphera Pharmaceuticals
Foundation Medicine
G1 Therapeutics
ID Medical Devices
Taiho Oncology
Takeda Oncology
Price
⚠ | COVID-19 Protocols Notice for All Attendees, Exhibitors and VendorsSelf-screening is required for all in-person attendees. If you have any symptoms of respiratory illness, you must refrain from attending in person. Please be sure to read our COVID Protocols for all in-person education prior to registering for this activity. |